OKYO Pharma Ltd Share Price Today: Live Updates & Key Insights

OKYO Pharma Ltd share price today is $1.57, up -3.09%. The stock opened at $1.6105 against the previous close of $1.62, with an intraday high of $1.67 and low of $1.55.

OKYO Pharma Ltd Share Price Chart

OKYO Pharma Ltd

us-stock
To Invest in {{usstockname}}
us-stock

OKYO Pharma Ltd Share Price Performance

$1.57 -0.0309(-3.09%) OKYO at 23 Mar 2026 02:35 PM Biotechnology
Lowest Today 1.55
Highest Today 1.67
Today’s Open 1.6105
Prev. Close 1.62
52 Week High 3.35
52 Week Low 1.03
Day’s Range: Low 1.55 High 1.67
52-Week Range: Low 1.03 High 3.35
1 day return -
1 Week return -5.98
1 month return -7.1
3 month return -24.88
6 month return -32.03
1 year return +33.05
3 year return +4.66
5 year return -
10 year return -

OKYO Pharma Ltd Institutional Holdings

Dauntless Investment Group, LLC 0.92

Renaissance Technologies Corp 0.27

Northern Trust Corp 0.11

HPM Partners LLC 0.02

Fidelity Nasdaq Composite Index 0.02

Geode Capital Management, LLC 0.02

Wealth Enhancement Advisory Services, LLC 0.02

EFG International AG 0.00

Advisor Group Holdings, Inc. 0.00

Citadel Advisors Llc 0.00

UBS Group AG 0.00

OKYO Pharma Ltd Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

OKYO Pharma Ltd Fundamentals

Market Cap 89.89 M

PB Ratio 14.1075

PE Ratio 0.0

Enterprise Value 76.62 M

Total Assets 3.68 M

Volume 83084

OKYO Pharma Ltd Company Financials

Annual Revenue FY25:0 0.0M, FY24:0 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M

Annual Profit FY25:-2563 -0.0M, FY24:-7506 -0.0M, FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M

Annual Net worth FY25:-4706292 -4.7M, FY24:-16825 -0.0M, FY23:-13271685 -13.3M, FY22:-4134492 -4.1M, FY21:-2997429 -3.0M

Quarterly Revenue Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q2/2023:null 0.0M, Q1/2023:null 0.0M

Quarterly Profit Q3/2025:-885 -0.0M, Q2/2025:-1289 -0.0M, Q1/2025:-1289 -0.0M, Q2/2023:-1566 -0.0M, Q1/2023:null 0.0M

Quarterly Net worth Q3/2025:-2586867 -2.6M, Q2/2025:-2026474 -2.0M, Q1/2025:-2026474 -2.0M, Q2/2023:-3095 -0.0M, Q1/2023:-1033623 -1.0M

About OKYO Pharma Ltd & investment objective

Company Information OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase II clinical trials for the treatment of dry eye disease; in Phase II clinical trial to treat neuropathic corneal pain; and is in preclinical trial to treat allergic conjunctivitis and uveitis. The company is also developing OK-201 for the treatment acute and chronic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Organisation Biotechnology

Employees 4

Industry Biotechnology

CEO Mr. Robert J. Dempsey M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

OKYO Pharma Ltd FAQs

What is the share price of OKYO Pharma Ltd today?

The current share price of OKYO Pharma Ltd is $1.57.

Can I buy OKYO Pharma Ltd shares in India?

Yes, Indian investors can buy OKYO Pharma Ltd shares by opening an international trading and demat account with Motilal Oswal.

How to buy OKYO Pharma Ltd shares in India?

You can easily invest in OKYO Pharma Ltd shares from India by:

Can I buy fractional shares of OKYO Pharma Ltd?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of OKYO Pharma Ltd?

OKYO Pharma Ltd has a market cap of $89.89 M.

In which sector does OKYO Pharma Ltd belong?

OKYO Pharma Ltd operates in the Biotechnology sector.

What documents are required to invest in OKYO Pharma Ltd stocks?

To invest, you typically need:

What is the PE and PB ratio of OKYO Pharma Ltd?

The PE ratio of OKYO Pharma Ltd is N/A and the PB ratio is 14.11.